Edesa Biotech, Inc.
EDSA
$1.45
-$0.03-2.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.46% | 14.56% | 19.42% | 20.85% | 26.32% |
| Total Depreciation and Amortization | -35.86% | -26.73% | -25.62% | -8.54% | 1.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.60% | -55.68% | -62.81% | -61.77% | -58.07% |
| Change in Net Operating Assets | -272.61% | -398.91% | -54.69% | 200.72% | 85.33% |
| Cash from Operations | -49.73% | -21.83% | 9.71% | 20.01% | 26.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | 958.09% | 517.97% | 300.08% | -56.68% | -85.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -426.44% | -282.46% | -187.44% | -8.43% | 62.23% |
| Cash from Financing | 2,776.84% | 1,523.03% | 912.45% | 6.02% | -87.74% |
| Foreign Exchange rate Adjustments | 278.38% | 224.75% | -3,400.00% | -340.39% | -133.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 325.59% | 333.70% | 337.54% | 32.43% | -150.01% |